Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Alexa Fluor 350-conjugated Antibody, R&D Systems™

Human Monoclonal Antibody

Supplier:  R&D Systems FAB9576U100UG

Catalog No. FAB9576U100

Description

CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples. It is validated for Flow Cytometry.

Specifications

• Antigen: CD30/TNFRSF8
• Classification: Monoclonal
• Conjugate: Alexa Fluor 350
• Formulation: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
• Host Species: Human
• Purification Method: Protein A or G purified from cell culture supernatant
• Primary or Secondary: Primary
• Test Specificity: Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
• Content And Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
• Isotype: IgG1

• Applications: Flow Cytometry
• Clone: Hu8
• Dilution: Flow Cytometry 0.25-1 ug/10^6 cells
• Gene Alias: CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
• Immunogen: Human CD30/TNFRSF8
• Quantity: 100 μg
• Gene ID (Entrez): 943
• Target Species: Human
• Form: Supernatant